Qube Research & Technologies LTD Werewolf Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $6.75 $254,353 - $733,711	-108,698 Reduced 92.89%	8,315 $20,000
Q1 2024 May 14, 2024	BUY	$3.92 - $7.91 $449,345 - $906,715	114,629 Added 4808.26%	117,013 $758,000
Q4 2023 Feb 13, 2024	BUY	$1.78 - $4.15 $4,239 - $9,885	2,382 Added 119100.0%	2,384 $9,000
Q3 2023 Nov 13, 2023	BUY	$2.0 - $3.82 $4 - $7	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$4.14 - $7.42 $10,875 - $19,492	-2,627 Reduced 11.66%	19,908 $90,000
Q2 2022 Aug 15, 2022	BUY	$3.43 - $5.98 $77,295 - $134,759	22,535 New	22,535 $92,000

31.8M

700

500

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $47M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.